Literature DB >> 21802760

Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes.

Pedro Romero-Aroca1, Marc Baget-Bernaldiz, Juan Fernandez-Ballart, Nuria Plana-Gil, Nuria Soler-Lluis, Isabel Mendez-Marin, Angel Bautista-Perez.   

Abstract

AIMS: To determine the 10-year incidence of diabetic retinopathy (DR) and macular edema (DME), and its relationship with its risk factors in a sample of type 1 diabetes mellitus.
METHODS: A total of 334 patients without diabetic retinopathy at baseline underwent a 10-year prospective study, the risk factors included: age, gender, diabetes duration, HbA1c, LDL-C, HDl-C, TC/HDL-C ratio, ApoA1, ApoB, ApoB/ApoA1 ratio, and triglycerides were recorded. Risk factors for diabetic macular edema (DME) were also recorded.
RESULTS: The 10-year incidence of any DR was 35.90%, and 11.07% developed DME. The risk factors for DR and DME were: diabetes duration, high glycosylated level, and arterial hypertension, and overt nephropathy was well correlated with DME. The lipid study demonstrated that ApoB/ApoA1 ratio was significant for any DR [HRR: 0.594 (0.416-0.848), p=0.01], and DME [HRR: 0.601 (0.433-0.894), p=0.009]. The TC/HDL ratio was only significant for DME [HRR: 0.624 (0.440-0.886), p=0.008]; other lipids values were not significant for any groups studied.
CONCLUSIONS: In the present study, the ApoB/ApoA1 ratio was significant to the 10-year incidence of diabetic retinopathy and to macular edema; and the TC/HDL ratio was significant to a 10-year incidence of macular edema. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21802760     DOI: 10.1016/j.diabres.2011.07.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  15 in total

1.  Prevalence, severity stages, and risk factors of diabetic retinopathy in 1464 adult patients with type 1 diabetes.

Authors:  Abir Zureik; Jean-Baptiste Julla; Ali Erginay; Tiphaine Vidal-Trecan; Vanessa Juddoo; Jean-François Gautier; Pascale Massin; Ramin Tadayoni; Jean-Pierre Riveline; Aude Couturier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-15       Impact factor: 3.117

Review 2.  Emerging pharmacotherapies for diabetic macular edema.

Authors:  Golnaz Javey; Stephen G Schwartz; Harry W Flynn
Journal:  Exp Diabetes Res       Date:  2012-02-26

3.  Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.

Authors:  Yoo-Ri Chung; Sung Wook Park; Shin-Young Choi; Seung Woo Kim; Ka Young Moon; Jeong Hun Kim; Kihwang Lee
Journal:  Cardiovasc Diabetol       Date:  2017-01-07       Impact factor: 9.951

4.  Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study.

Authors:  Pedro Romero-Aroca; Raul Navarro-Gil; Aida Valls-Mateu; Ramon Sagarra-Alamo; Antonio Moreno-Ribas; Nuria Soler
Journal:  Br J Ophthalmol       Date:  2017-03-07       Impact factor: 4.638

Review 5.  Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis.

Authors:  Yue Zhou; Changyun Wang; Ke Shi; Xiaolong Yin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

6.  Type 1 Diabetic Subjects with Diabetic Retinopathy Show an Unfavorable Pattern of Fat Intake.

Authors:  Minerva Granado-Casas; Anna Ramírez-Morros; Mariona Martín; Jordi Real; Núria Alonso; Xavier Valldeperas; Alicia Traveset; Esther Rubinat; Nuria Alcubierre; Marta Hernández; Manel Puig-Domingo; Albert Lecube; Esmeralda Castelblanco; Didac Mauricio
Journal:  Nutrients       Date:  2018-08-29       Impact factor: 5.717

7.  Service usage and vascular complications in young adults with type 1 diabetes.

Authors:  Steven James; Lin Perry; Robyn Gallagher; Julia Lowe; Janet Dunbabin; Patrick McElduff; Shamasunder Acharya; Katharine Steinbeck
Journal:  BMC Endocr Disord       Date:  2014-05-09       Impact factor: 2.763

Review 8.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30

Review 9.  Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.

Authors:  Mark T Bolinger; David A Antonetti
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

10.  Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China.

Authors:  Yan Liu; Jiarui Yang; Liyuan Tao; Huibin Lv; Xiaodan Jiang; Mingzhou Zhang; Xuemin Li
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.